Stock Trend Analysis Report
Prepared for you on Sunday, October 2, 2022.
PROVECTUS BIOPHARMS (NASDAQ:PVCT)
Long-Term Downtrend (-90) - PVCT is in a strong downtrend that is likely to continue. While PVCT is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid PVCT?
MarketClub looks at technical strength and momentum to determine if the timing is right for PVCT.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for PVCT
The long-term trend has been DOWN since Apr 8th, 2022 at 0.0550
The intermediate-term trend has been DOWN since Sep 6th, 2022 at 0.0485
The short-term trend has been DOWN since Sep 23rd, 2022 at 0.0482
Smart Scan Analysis for PVCT
Based on our trend formula, PVCT is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||0.092||Year High Date||2018-01-02|
|Year Low||0.055||Year Low Date||2018-03-26|
|52wk High||0.0734||52wk High Date||2022-01-10|
|52wk Low||0.0421||52wk Low Date||2021-12-14|
|Average Volume||164,344||Shares Outstanding||419,447|